Evidence map›Paper›PMID 19924305›Full record

ArticlePloS one2009

A cell motility screen reveals role for MARCKS-related protein in adherens junction formation and tumorigenesis.

Alexander E Finlayson, Kevin W Freeman

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in PloS one, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06536413 (Phase IB/II Study Combining All-Trans Retinoic Acid), which is not on this map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06536413 phase1 / phase2recruitingnot on this mapstarted 2024, after this paper: background citation

Phase IB/II Study Combining All-Trans Retinoic Acid (ATRA) With Carfilzomib Based Therapy in Plasma Cell Myeloma Patients Refractory to Carfilzomib

TypeinterventionalSponsorThe Methodist Hospital Research InstituteRan2024 to 2030Enrolled42ConditionsMultiple MyelomaArmsAll-Trans Retinoic Acid (ATRA) Dose 0, All-Trans Retinoic Acid (ATRA) Dose -1, All-Trans Retinoic Acid (ATRA) Dose 1
3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Wnt3a: functions and implications in cancer.Chinese journal of cancer · 2015
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Alexander E FinlaysonDepartment of Genetics, Harvard Medical School, Boston, Massachusetts, USA.
Kevin W Freeman
Harvard University · US

Funding

Transcriptional repressors of E-cadherin in metastasisF32CA112989 · NCI · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI FREEMAN, KEVIN W · 2005 to 2007
$118k
NCI NIH HHS F32 CA112989
6 · The paper itself

Abstract

Invasion through the extracellular matrix (ECM) is important for wound healing, immunological responses and metastasis. We established an invasion-based cell motility screen using Boyden chambers overlaid with Matrigel to select for pro-invasive genes. By this method we identified antisense to MARCKS related protein (MRP), whose family member MARCKS is a target of miR-21, a microRNA involved in tumor growth, invasion and metastasis in multiple human cancers. We confirmed that targeted knockdown of MRP, in both EpRas mammary epithelial cells and PC3 prostate cancer cells, promoted in vitro cell migration that was blocked by trifluoperazine. Additionally, we observed increased immunofluoresence of E-cadherin, beta-catenin and APC at sites of cell-cell contact in EpRas cells with MRP knockdown suggesting formation of adherens junctions. By wound healing assay we observed that reduced MRP supported collective cell migration, a type of cell movement where adherens junctions are maintained. However, destabilized adherens junctions, like those seen in EpRas cells, are frequently important for oncogenic signaling. Consequently, knockdown of MRP in EpRas caused loss of tumorigenesis in vivo, and reduced Wnt3a induced TCF reporter signaling in vitro. Together our data suggest that reducing MRP expression promotes formation of adherens junctions in EpRas cells, allowing collective cell migration, but interferes with oncogenic beta-catenin signaling and tumorigenesis.

Indexed as

Cell Transformation, NeoplasticAdherens Junctionsbeta CateninCadherinsCalmodulin-Binding ProteinsCell CommunicationCell Line, TumorCell MovementHumansMembrane ProteinsMicrofilament ProteinsMicroRNAsMicroscopy, FluorescenceNeoplasm MetastasisSignal TransductionWound Healingbeta CateninCadherinsCalmodulin-Binding ProteinsMARCKSL1 protein, humanMembrane ProteinsMicrofilament ProteinsMicroRNAsMIRN21 microRNA, human

Identifiers

PMID19924305
PMCPMC2774968
OpenAlexW2092593065

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.